Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Will Biotech Unicorns Soon Be on The Endangered Species List?
BioSpace
Wed, 07/13/22 - 10:41 am
biotech
unicorns
IPOs
Pliant Therapeutics Announces Pricing of Upsized $200.0 Million Public Offering
BioSpace
Tue, 07/12/22 - 11:36 pm
Pliant Therapeutics
IPOs
Biotech IPO freeze continues as second quarter is slowest in more than a decade
MedCity News
Wed, 07/6/22 - 10:38 am
IPOs
biotech
Solta Medical
Bausch Health
At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price
Endpoints
Mon, 05/23/22 - 06:45 pm
AstraZeneca
IPOs
Enstasis
antibiotics
For medtechs seeking deals, it’s hurry up and wait
EP Vantage
Mon, 05/9/22 - 09:56 am
Medtech
devices
IPOs
M&A
With Sarepta in its sights, PepGen prices IPO to fund DMD trials
Fierce Biotech
Fri, 05/6/22 - 10:55 am
PepGen
IPOs
Sarepta Therapeutics
Duchenne Muscular Dystrophy
HilleVax’s IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda
MedCity News
Mon, 05/2/22 - 11:46 am
IPOs
vaccines
HilleVax
Takeda
norovirus
After a record run, fewer biotechs are going public. Here's how they're performing.
BioPharma Dive
Fri, 04/22/22 - 10:42 am
biotech
IPOs
Biotech startups face 'trickle-down effects' as sector's IPO drought endures
BioPharma Dive
Mon, 04/11/22 - 10:25 am
IPOs
startups
Biopharma flotations tank in the first quarter
EP Vantage
Thu, 04/7/22 - 10:11 am
Amylyx Pharmaceuticals
CinCor Pharma
Arcellx
Vigil Neuroscience
AN2 Therapeutics
IPOs
Belite Bio hits go on IPO to fund late-phase vision loss clinical trials
Fierce Biotech
Wed, 04/6/22 - 12:13 pm
Belite Bio
IPOs
clinical trials
vision loss
Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter
Endpoints
Fri, 03/25/22 - 10:29 am
AN2 Therapeutics
lung disease
funding
RA Capital
venture capital
IPOs
Going...going...gone. A small biotech throws in its IPO cards after market meltdown
Endpoints
Mon, 03/21/22 - 10:22 pm
Sagimet Biosciences
IPOs
NASH
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease
Financing roundup: Electra’s Star debut, Kallyope’s cash, Memo’s money & more
MedCity News
Tue, 02/22/22 - 10:48 am
biotech
IPOs
Electra Therapeutics
Kallyope
Memo Therapeutics
Centauri Therapeutics
SpliceBio
Third Harmonic Bio
Synthego
NMD Pharma
funding
Biotech IPOs in the current market environment? Experts say it's 'a bit silly, if not suicidal'
Fierce Biotech
Tue, 02/22/22 - 10:40 am
biotech
IPOs
pandemic
COVID-19
Arcellx’s IPO raises $124M to fuel chase of better CAR T-cell therapy for cancer
MedCity News
Tue, 02/8/22 - 09:53 am
Arcellx
IPOs
CAR-T
funding
cell therapy
Multiple Myeloma
No regrets as Lyell prepares for its first clinical trial
EP Vantage
Mon, 02/7/22 - 11:13 am
Lyell Immunopharma
IPOs
clinical trials
cell therapy
cancer
oncology
'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for IPOs
BioPharma Dive
Mon, 02/7/22 - 10:08 am
biotech
startups
IPOs
funding
Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T
Fierce Biotech
Fri, 02/4/22 - 11:01 am
Arcellx
IPOs
Multiple Myeloma
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »